Dr. Jignesh Patel
Shree S. K. Patel College of Pharma Edu and Research, Ganpat University, Parul University, Certara University, Indian Institute of Public Health Gandhinagar, CBCC Global Research
0000-0002-6056-8189
About
• Dr.Jignesh Patel is pharmaceutical scientist with having more than 20 years of experience in pharmaceutical research contributing to >100 therapeutic products in market treating >1 lakh patients every year.
• He has done his bachelor & master in pharmacy from L.M.College of Pharmacy (LMCP), and PhD in Pharmacology under the guidance of Dr.R.K.Goyal, Professor at LMCP and Ex-vice-chancellor of M.S.University, Vadodara. He has done various clinical pharmacology courses from NIH, USA.
• He had published >40 articles in various scientific journals indexed in Pubmed, Scopus etc.
• He has received many national and international awards of US$2200, Rs.131000, US$500 from UK, USA, Australia etc. for his research work and scientific publications.
• He had worked with India’s top pharmaceutical industry, Sun Pharma’s R & D Centre, Vadodara for 10 years as “In-charge of Phase 1 clinical trial unit with human pharmacodynamics lab”. Dr.Jignesh is pioneer of setting up India’s first phase 1 clinical trial unit of Sun Pharma in 2008. He is also the pioneer of setting up India’s dedicated first Phase 1 clinical trial unit & human pharmacodynamics labs of CBCC Global Research, India & USA in 2018.
• He has directly led clinical development of more than 10 New Medicines INDs for USFDA, more than 14 NDDS, 37 medical devices, 3 Biosimilars, 2 vaccines & more than 140 generic products for USFDA, EMA, MHRA and other regulatory market. During his early career, he has worked at various hospitals and has handled clinical trials of global pharma industries including Sanofi, GSK, Pfizer, BMS, Boehringer Ingelheim, J & J, Medtronic, AstraZeneca, Novartis etc. for global clinical trial in Europe and UK hospital sites.
• He has faced and cleared regulatory audits for clinical trials from USFDA, EMA, MHRA, CDSCO, ANVISA, Malaysia Regulatory Authority.
• Currently he is working as Professor, PhD Guide and Head: Clinical Research Department at Parul University.
• His areas of expertise include translational research, clinical development strategy designing and first-in-human clinical trials, SAD-MAD studies, thorough QT-QTc studies, human pharmacodynamics and various clinical pharmacology studies, design, conduct, analysis and interpretation of clinical trials of drugs, modified release formulations, NDDS, biologics, biosimilars, medical devices and vaccines to make "Go" or "No Go" decisions.
Employment
-
Shree S. K. Patel College of Pharma Edu and Research, Ganpat University Professor, PhD Guide & Industry Consultant2026 - Present
-
Parul University Professor, PhD Guide, Head & Industry Consultant2022 - 2025
-
CBCC Global Research Senior Director2018 - 2022
-
Sun Pharmaceutical Industries Ltd In-charge2008 - 2018
-
VIBGYOR Scientific Research Pvt. Ltd. (Now, have merged in CBCC Global Research) Manager2006 - 2008
-
Ganpat University Assistant Professor2002 - 2006
-
Sterling Hospitals Clinical Scientist2002 - 2004
-
Intas Pharmaceuticals (India) Intern Production Officer2000 - 2000
Education
-
Certara University Noncompartmental Data Analysis (NCA) in Pharmacokinetics2022 - 2022
-
Indian Institute of Public Health Gandhinagar Certificate in Research Methodology2013 - 2014
-
National Institute of Health Course in Clinical Pharmacology and Clinical Research2007 - 2020
-
National Cancer Institute Course on Human Participants Protection2007 - 2007
-
North Gujarat University PhD: Pharmacology2002 - 2006
-
L.M.College of Pharmacy M.Pharm.:Pharmacology2000 - 2002
-
L.M.College of Pharmacy B.Pharm.1996 - 2000
Projects & Funding
Projects & funding information is unavailable.
Publications (42)
- A Rare Case of Acute Motor Axonal Neuropathy in a One-Year-Old Male Child Save
- Scientific Principles of Beneficial Effects of Yoga Practices in COVID19 Save
- Covid19, Mucociliary Clearance And Mechanisms of Beneficial Effects of Various Yoga Practices Save
- Basic Principles and Objectives of Clinical Pharmacology Studies Save
- Burden of Diseases in India and How to Overcome from it with the Help of Ayurveda and Yoga Save
- All that is CCP positive RA is not severe! Save
- Do early primary sjogren's subjects have the referral bias of more extra glandular presentations? Save
- Is CDAI enough to assess disease activity in RA subjects in a resource poor population ? Save
- Psoriatic arthritis: demography, clinical features and PASI Save
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects Save